Join to View Full Profile
500 University DrH088Hershey, PA 17033
Phone+1 717-531-6585
Fax+1 717-531-0429
Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2007 - 2010
Capital University of Medical SciencesClass of 1995
Certifications & Licensure
PA State Medical License 2007 - 2026
CA State Medical License Active through 2013
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.Natasha Venugopal, Andrew McGowan, Yoshitaka Inoue, Hong Zheng, Joseph Cioccio
Annals of Hematology. 2025-10-13 - Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell t...Claudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej
British Journal of Haematology. 2025-08-01 - Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.Chenchen Zhao, Bei Jia, Yixing Jiang, Hiroko Shike, Charyguly Annageldiyev
Cancer Immunology, Immunotherapy. 2025-02-25
Abstracts/Posters
- Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute LeukemiaHong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Hong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Graft-Versus-Host Disease Causes the Failure of Donor Hematopoietic Progenitor Cells to Reconstitute Plasmacytoid Dendritic Cells That Promote Tolerance of Donor T Cel...Hong Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Effect of Avelumab to Immune Response in AML: A Phase I Study of Avelumab in Combination with Decitabine As First Line Treatment of Unfit Patients61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Multi-Dimensional Analysis of Immune Signature Predicts Response to Decitabine Treatment in Elderly Patients with AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Cost-Effectiveness of Different Surgical Treatment Approaches for Early Breast Cancer: A Retrospective Matched Cohort Study from ChinaFebruary 2nd, 2021
Researchers Discover a Potential Biomarker for AML Relapse After Stem Cell TransplantSeptember 24th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
